
Psychemedics Corporation PMD
Quarterly report 2024-Q3
added 11-12-2024
Psychemedics Corporation EV/EBITDA Ratio 2011-2026 | PMD
Annual EV/EBITDA Ratio Psychemedics Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 15.9 | -15.9 | 8.06 | 9.37 | 9.92 | 11.2 | 16.9 | 14.4 | 11.8 | 10.8 | 7.23 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 16.9 | -15.9 | 9.05 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
0.387 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
28.1 | - | -17.87 % | $ 25.9 M | ||
|
Bioventus
BVS
|
26.4 | $ 8.9 | 0.39 % | $ 593 M | ||
|
Brainsway Ltd.
BWAY
|
-43.6 | $ 13.85 | 1.47 % | $ 99.4 M | ||
|
Castle Biosciences
CSTL
|
-21.2 | $ 26.04 | 0.81 % | $ 723 M | ||
|
Aspira Women's Health
AWH
|
-2.63 | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
39.5 | $ 68.33 | 2.99 % | $ 26.7 B | ||
|
Guardant Health
GH
|
-28.8 | $ 87.63 | 0.52 % | $ 11 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | ||
|
Charles River Laboratories International
CRL
|
22 | $ 154.73 | 1.82 % | $ 7.67 B | ||
|
CareDx, Inc
CDNA
|
-100 | $ 17.59 | 1.56 % | $ 937 M | ||
|
Accelerate Diagnostics
AXDX
|
-5.56 | - | -61.36 % | $ 2.46 M | ||
|
IQVIA Holdings
IQV
|
24.1 | $ 168.86 | 2.41 % | $ 29 B | ||
|
Exact Sciences Corporation
EXAS
|
-20.8 | $ 103.89 | 0.04 % | $ 19.6 B | ||
|
Global Cord Blood Corporation
CO
|
-3.52 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-13.6 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-2.67 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-2.67 | - | 0.12 % | $ 80.1 M | ||
|
Fulgent Genetics
FLGT
|
2.58 | $ 15.62 | 4.45 % | $ 472 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
20.8 | - | - | $ 10.7 B | ||
|
Biodesix
BDSX
|
-4.25 | $ 16.88 | -2.37 % | $ 2.19 B | ||
|
ICON Public Limited Company
ICLR
|
38 | $ 100.35 | 2.81 % | $ 8.28 B | ||
|
Anixa Biosciences
ANIX
|
-2.25 | $ 2.9 | 2.11 % | $ 94.1 K | ||
|
Danaher Corporation
DHR
|
20.1 | $ 195.77 | 2.29 % | $ 140 B | ||
|
NeoGenomics
NEO
|
-33.5 | $ 8.36 | 1.46 % | $ 1.07 B | ||
|
Biocept
BIOC
|
-26.9 | - | -13.05 % | $ 7.29 M | ||
|
Heska Corporation
HSKA
|
141 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-1.42 | - | -20.0 % | $ 1.06 M | ||
|
Pacific Biosciences of California
PACB
|
-23.8 | $ 1.4 | 2.95 % | $ 420 M | ||
|
Illumina
ILMN
|
70.5 | $ 121.89 | 2.18 % | $ 19.4 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.51 | $ 198.82 | -0.06 % | $ 22.1 B | ||
|
QIAGEN N.V.
QGEN
|
13.2 | - | - | $ 10.6 B | ||
|
Agilent Technologies
A
|
27.4 | $ 113.9 | 1.85 % | $ 34.6 B | ||
|
BioNano Genomics
BNGO
|
-7.71 | $ 1.12 | 0.9 % | $ 1.42 M | ||
|
DarioHealth Corp.
DRIO
|
-1.05 | $ 9.28 | 10.24 % | $ 263 M | ||
|
Neogen Corporation
NEOG
|
40.3 | $ 9.32 | 2.25 % | $ 2.02 B | ||
|
Lantheus Holdings
LNTH
|
-187 | $ 78.96 | 0.59 % | $ 5.33 B | ||
|
Chembio Diagnostics
CEMI
|
-1.23 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
-0.674 | - | - | $ 9.42 M | ||
|
Co-Diagnostics
CODX
|
3.62 | $ 4.4 | 101.83 % | $ 129 M | ||
|
Medpace Holdings
MEDP
|
30.7 | $ 452.34 | -0.29 % | $ 13 B | ||
|
Motus GI Holdings
MOTS
|
0.351 | - | -34.28 % | $ 263 K | ||
|
Mettler-Toledo International
MTD
|
827 | $ 1 219.76 | 1.76 % | $ 25.1 B | ||
|
Celcuity
CELC
|
-2.38 | $ 114.23 | -0.58 % | $ 4.51 B | ||
|
DermTech
DMTK
|
-2.44 | - | -11.32 % | $ 2.94 M | ||
|
Twist Bioscience Corporation
TWST
|
-23.6 | $ 46.61 | 3.55 % | $ 2.79 B | ||
|
National Research Corporation
NRC
|
21 | $ 18.05 | 3.71 % | $ 404 M | ||
|
Invitae Corporation
NVTA
|
-10.7 | - | - | $ 21.2 M | ||
|
Enzo Biochem
ENZ
|
58.3 | - | -8.98 % | $ 14.8 K | ||
|
Natera
NTRA
|
-19.5 | $ 199.84 | 1.09 % | $ 19.7 B |